2022 Pediatric Grand Rounds | Treatment-Associated Cardiotoxicity in Pediatric Acute Myeloid Leukemia: Occurrence and Implications

Duarte, CA US
August 4, 2022

Cardiotoxicity is an important complication after AML chemotherapy which can affect post-treatment quality of life and treatment related mortality. There are new options for risk assessment and cardiotoxicity prevention which are critical for long term cardiac outcome. This lecture is designed to educate healthcare providers on improving communication, patient screening and post treatment monitoring to close the knowledge gap. This will improve patient outcomes and cardiac health. 

Target Audience

City of Hope Pediatric Hematology/Oncology Physicians, Advance Practice Practitioners, City of Hope staff and research teams

Learning Objectives

  • Describe the patterns of decline and resolution of cardiac function during and after frontline treatment for AML.
  • Discuss the incidence and identify risk factors for early cardiotoxicity during AML therapy.
  • Discuss the impacts of early cardiotoxicity on event free and overall survival outcome following AML therapy.
  • Assess the benefits and risks of medications considered for cardio protection during frontline AML.
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2022 Pediatric Grand Rounds | Treatment-Associated Cardiotoxicity in Pediatric Acute Myeloid Leukemia: Occurrence and Implications for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
08/04/2022
Activity expires: 
08/09/2022
Event starts: 
08/04/2022 - 12:00pm PDT
Event ends: 
08/04/2022 - 1:00pm PDT
Add to calendar: 
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

KELLY D. GETZ, PHD, MPH  Assistant Professor, Epidemiology and Pediatrics; Perelman School of Medicine at the University of Pennsylvania, CHOP Research Institute and Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia

Dr. Getz indicated she has nothing to disclose.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2022 Pediatric Grand Rounds | Treatment-Associated Cardiotoxicity in Pediatric Acute Myeloid Leukemia: Occurrence and Implications for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.